NCT01089309View on ClinicalTrials.gov

Effect of Aldosterone Blockade on Arterial Compliance

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Arterial StiffnessArterial Elasticity
Interventions
DRUG

Spironolactone

Spironolactone orally, at a dose of 50 mg/day for 12 months

Trial Locations (1)

58100

Wolfson Medical Center, Holon

All Listed Sponsors
lead

Wolfson Medical Center

OTHER_GOV

NCT01089309 - Effect of Aldosterone Blockade on Arterial Compliance | Biotech Hunter | Biotech Hunter